Three U.S. senators are calling on Robert Kennedy Jr. to disclose what he and President Trump discussed with drugmakers ...

President Donald Trump’s nominee for FDA Commissioner, Martin A. Makary, MD, sought to assure senators that if confirmed, he would support efforts to expedite reviews of new drugs indicted for rare ...

A federal pharmaceutical testing facility in St. Louis will remain open, despite appearing on DOGE’s list of scheduled office ...

The Senate hearing for FDA Commissioner nominee Marty Makary comes after President Trump's NIH pick, Jay Bhattacharya, was ...

Health experts have slammed the FDA as 'corrupt' and 'in bed with Big Pharma' after its former drug chief Dr Patrizia Cavazzoni left the agency to serve as chief medical officer of Pfizer.

Without enough staff at the CDER, which receives user fees, the FDA could find itself in a position where it's not able to use access its fees, according to the lawmakers. “This would be ...

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the company announced Monday. Patrizia Cavazzoni was formerly director of the ...

The former CDER leader will succeed Aida Habtezion, M.D., who served as Pfizer’s CMO and head of worldwide medical and safety for four years, and will be leaving the pharma to "pursue other ...

The hammer came down on an unspecified number of FDA employees this weekend, days after Robert F. Kennedy Jr. was confirmed as HHS Secretary. The worst fears of several FDA staffers were realized on ...

"The FDA has now approved three biosimilar insulin products to treat diabetes," said Peter Stein, MD, director of the Office of New Drugs at CDER. "Today's approval highlights our continued ...